TATACHEM NSE filing

Tata Chemicals Q1 FY27 Results: Board Approves Unaudited Consolidated & Audited Standalone Financials

The RealCase readMedium impact Neutral

Tata Chemicals Limited's Board approved Q1 FY27 unaudited consolidated and audited standalone financial results on July 27, 2026. Standalone profit after tax was ₹343 crore on revenue of ₹1,281 crore. Consolidated results include a ₹26 crore net loss share from a joint venture and ₹9 crore net profit from an associate/joint ventures.

Why it matters

The announcement pertains to the quarterly financial results, which are a material event for investors and stakeholders. The detailed financial figures and reports provide crucial information for assessing the company's performance.

The market read

The announcement reports the outcome of a board meeting where financial results were approved. While it presents financial data, there are no significant positive or negative developments highlighted that would strongly sway the sentiment.

Tata Chemicals Limited announced the outcome of its Board Meeting held on July 27, 2026. The Board of Directors approved the Unaudited Consolidated and Audited Standalone Financial Results for the quarter ended June 30, 2026.

The Board Meeting commenced at 2:00 p.m. IST and concluded at 4:10 p.m. IST. Copies of the Financial Results, along with the Auditors' Report/Limited Review Report, have been enclosed and will be made available on the company's website (www.tatachemicals.com). The results will also be published in an English and a vernacular newspaper.

The accompanying limited review report for the consolidated financial results indicates that for the quarter ended June 30, 2026, the Group's share of net loss after tax from a joint venture was ₹26 crore. Additionally, the Group's share of net profit after tax from an associate and two joint ventures was ₹9 crore. The report also notes a total comprehensive income of ₹66 crore from these entities, based on financial information that was not reviewed by the auditors but was deemed not material to the Group.

The standalone financial results for the quarter ended June 30, 2026, show a Profit before tax of ₹392 crore and a Profit after tax of ₹343 crore. Total comprehensive income for the period stood at ₹1,222 crore. The company reported revenue from operations of ₹1,281 crore and total income of ₹1,497 crore for the standalone entity. Key financial ratios such as Operating Margin and Net Profit Margin are also provided. The company's net worth as of June 30, 2026, was ₹19,053 crore.

Filing to action

What to do with a filing like this

Tata Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Tata Chemicals Limited. Read the original for the full detail.

View original filing